A contemporary review of "realistic" success rates after surgical closure of nasal septal perforations.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 21 01 2021
revised: 05 03 2021
accepted: 16 03 2021
pubmed: 7 4 2021
medline: 5 1 2022
entrez: 6 4 2021
Statut: ppublish

Résumé

The surgical closure of septal perforations is a challenging procedure. Various techniques exist. Each perforation proves that there is not the one precise procedure for all perforations. Nevertheless, success rates of about 90% are reported, although the procedure for closing the defect is challenging. Our goal was to evaluate the existing data. We performed a contemporary review of published closure rates of septal perforations on order to compare the present results in the literature. The limitations of the respective studies were analyzed. We found closure rates from 30 to 100%. Numerous procedures were described and combined. Prospective studies comparing different techniques are missing. The follow-up time in studies was quite short or not even specified. Studies on long-term success rates are rare. The closure of septal defects is one of the most challenging rhinosurgical interventions. Closure rates ≥90% as described in literature seem relatively high. One reason might be short follow-ups and retrospective study designs. Frequently, precise information on the follow-up and the method of follow up is missing. Thoroughly designed prospective studies are absent. Longer follow-up times are associated with lower complete closure rates. A long-term success rate between 70 and 80% seems realistic.

Identifiants

pubmed: 33820666
pii: S0385-8146(21)00088-2
doi: 10.1016/j.anl.2021.03.013
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1039-1046

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Joerg Lindemann (J)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany. Electronic address: joerg.lindemann@uniklinik-ulm.de.

Eva Goldberg-Bockhorn (E)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Marc O Scheithauer (MO)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Thomas K Hoffmann (TK)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Fabian Sommer (F)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Franziska Stupp (F)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Hannah L Sieron (HL)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH